PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors that regulate lipid and glucose metabolism and cellular differentiation. PPAR-alpha and PPAR-gamma are both expressed in human macrophages where they exert anti-inflammatory effects. The activation of PPAR-alpha may promote foam-cell formation by inducing expression of the macrophage scavenger receptor CD36. This prompted us to investigate the influence of different PPAR-activators on cholesterol metabolism and foam-cell formation of human primary and THP-1 macrophages. Here we show that PPAR-alpha and PPAR-gamma activators do not influence acetylated low density lipoprotein-induced foam-cell formation of human macrophages. In contrast, PPAR-alpha and PPAR-gamma activators induce the expression of the gene encoding ABCA1, a transporter that controls apoAI-mediated cholesterol efflux from macrophages. These effects are likely due to enhanced expression of liver-x-receptor alpha, an oxysterol-activated nuclear receptor which induces ABCA1-promoter transcription. Moreover, PPAR-alpha and PPAR-gamma activators increase apoAI-induced cholesterol efflux from normal macrophages. In contrast, PPAR-alpha or PPAR-gamma activation does not influence cholesterol efflux from macrophages isolated from patients with Tangier disease, which is due to a genetic defect in ABCA1. Here we identify a regulatory role for PPAR-alpha and PPAR-gamma in the first steps of the reverse-cholesterol-transport pathway through the activation of ABCA1-mediated cholesterol efflux in human macrophages.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This mechanism is pivotal in controlling intracellular lipid content and serves as a primary “gatekeeper” for reverse cholesterol transport in cells [23].”
From miR-223 accelerates lipid droplets clearance in microglia following spinal cord injury by upregulating ABCA1 (2024) · cites this paper as [23]
In the citing paper
“The activation of PPARα also accelerates reverse cholesterol transport (RCT) via increased expression of ABCA1 and ABCG1 transporters involved in cholesterol efflux from macrophages [29, 40].”
From Pemafibrate, a new selective PPARα modulator: drug concept and its clinical applications for dyslipidemia and metabolic diseases (2020) · cites this paper as [40]
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630 · cited 1×
“, and this led to the suggestion that PPAR-activators may modulate foam-cell formation, a known atherogenic process characterized by cholesteryl-ester-droplet accumulation in the cytoplasm of macrophage”
BackgroundThe peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899 · cited 1×
“Both PPAR-α and PPAR-γ are expressed in fully-differentiated human macrophages where they regulate genes implicated in the inflammatory response, modulate macrophage differentiation and promote TNF-α/IFN-γ–induced apoptosi”
BackgroundThe PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816 · cited 1×
“We treated these cells with either the PPAR-α ligand Wy14643 or the PPAR-γ ligand rosiglitazone at concentrations of 2–3 times their EC 50 values (Wy14643 EC 50 for human PPAR-αe25 μM and rosiglitazone EC 50 for human PPAR-γe43 nM”
PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81575-5 · Cited by 1,797 · cited 1×
“Moreover, PPAR-α activation results in the transcriptional induction of CD36 expression in macrophage”
BackgroundMechanism of Action of Fibrates on Lipid and Lipoprotein Metabolism
Staels, B., Dallongeville, J., Auwerx, J., Schoonjans, K., Leitersdorf, E., & Fruchart, J.-C. (1998) · Circulation · doi:10.1161/01.cir.98.19.2088 · Cited by 1,786 · cited 1×
“The stimulatory role of PPAR-α activators on hepatic HDL production and apoAI expression is well-documente”
BackgroundSelf-citationMutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L.-H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O. F., et al. (1999) · Nature Genetics · doi:10.1038/11905 · Cited by 1,687
An oxysterol signalling pathway mediated by the nuclear receptor LXRα
Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R., & Mangelsdorf, D. J. (1996) · Nature · doi:10.1038/383728a0 · Cited by 1,591 · cited 1×
“We also show that both PPAR-α and PPAR-γ activators induce ABCA1 expression, possibly through their inductive effects on expression of LXR-α, a nuclear receptor activated by oxysterol”
Background
Cited by
Items 601–700 of 1,000
Zhang, Y., Zhao, Z., Kong, P., Gao, L., Yu, Y., Liu, J., Wang, P., Li, B., Zhang, X., Yang, L., et al. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0352-3 · Cited by 30
Patel, D. B., Walitt, B. T., Lindsay, J. M., & Wilensky, R. L. (2011) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2010.10.016 · Cited by 30
α-Tocopherol disturbs macrophage LXRα regulation of ABCA1/G1 and cholesterol handling
Rode, S., Rubic, T., & Lorenz, R. L. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.02.132 · Cited by 30
HDL does not influence the polarization of human monocytes toward an alternative phenotype.
Colin, S., Fanchon, M., Belloy, L., Bochem, A., Copin, C., Derudas, B., Stroes, E., Hovingh, G., Kuivenhoven, J., Dallinga-Thie, G., et al. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.12.168 · Cited by 29
“Moreover, in our experience, macrophage gene expression profile generally well reflects the macrophage functional phenotype [33,34].”
BackgroundSelf-citationPitavastatin increases ABCA1-mediated lipid efflux from Fu5AH rat hepatoma cells
Zanotti, I., Favari, E., Sposito, A. C., Rothblat, G. H., & Bernini, F. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.020 · Cited by 29
Nakaya, H., Summers, B. D., NICHOLSON, A. C., Gotto, A. M., Hajjar, D. P., & Han, J. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080611 · Cited by 32
Apolipoprotein A-I and risk for cardiovascular diseases
Arnold, N., & Köenig, W. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0033-9 · Cited by 31
Luoma, P. V. (2007) · Annals of Medicine · doi:10.1080/07853890701379767 · Cited by 29
“Identification of the endogenous ligands and physiological functions for PPARs (48,63), FXR, and several other nuclear receptors (148) and ABC transporters (28) further clarified processes controlling cholesterol homeosta- sis.”
BackgroundInfluentialSong, Y., Zhang, L., Li, H., Gu, Y., Li, F., Jiang, L., Liu, F., Ye, J., & Li, Q. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-111 · Cited by 30
Past and current perspective on new therapeutic targets for Type-II diabetes
Patil, P. D., Mahajan, U. B., Patil, K. R., Chaudhari, S. T., Patil, C. R., Agrawal, Y. O., Ojha, S. K., & Goyal, S. N. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s133453 · Cited by 33
“Similarly, use of peroxisome proliferator-activated receptor (PPAR-γ) agonists is associated with weight gain, fluid retention, urinary bladder cancer, osteoporosis and cardiovascular complications.(14) Rosiglitazone is PPAR agonist and widely used anti-diabetic drug.”
BackgroundFernández, A. Z. (2008) · PPAR Research · doi:10.1155/2008/285842 · Cited by 30
“direct involvement of PPAR in the gene-specific transcription, PPAR could also repress the transcription of certain genes brought about by the proinflammatory transcription factors, nuclear factor (NF)-κB, activation protein-1 (AP1), and signal transducer and activator of transcription 1 (STAT-1), through the binding…”
Murthy, S., Born, E. J., Mathur, S. N., & Field, F. J. (2004) · Biochemical Journal · doi:10.1042/bj20030903 · Cited by 29
Effects of the Thiazolidinediones on Cardiovascular Risk Factors
Gilling, L., Suwattee, P., Desouza, C. V., Asnani, S., & Fonseca, V. A. (2002) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200202030-00002 · Cited by 29
Lipid metabolism and neuroinflammation: What is the link?
Tiwari, V., & Simons, M. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20241232 · Cited by 43
Saliba‐Gustafsson, P., Pedrelli, M., Gertow, K., Werngren, O., Janas, V., Pourteymour, S., Baldassarre, D., Tremoli, E., Veglia, F., Rauramaa, R., et al. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12951 · Cited by 30
“LXR is one of the major transcriptional regulators of ABCA1 expression [24], and LXR deficiency leads to macrophage foam cell formation that is paralleled by increased LDL and reduced HDL cholesterol [25].”
BackgroundSutthasupha, P., & Lungkaphin, A. (2020) · Food & Function · doi:10.1039/d0fo00302f · Cited by 28
Rotllán, N., Llaverías, G., Julve, J., Jauhiainen, M., Calpe‐Berdiel, L., Hernández, C., Simó, R., Blanco‐Vaca, F., & Escolá‐Gil, J. C. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.11.006 · Cited by 30
“Furthermore, fibrates and other selective PPARα agonists increasedmacrophage cholesterol efflux in vitro by upregulating ATP-binding cassette transporter A1 (ABCA1) and limited macrophage foam cell formation and atherosclerosis [17–19].”
BackgroundA novel haplotype in ABCA1 gene effects plasma HDL-C concentration
Saleheen, D., Khanum, S., Haider, S. R., Nazir, A., Ahmad, U., Khalid, H., Hussain, I., Shuja, F., Kamran, S., Habib, A., et al. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.12.020 · Cited by 28
“The activated LXRs and RXRs bind to the response elements of various target genes including ABCA1 resulting in their increased transcription [31].”
BackgroundYang, Z., Bando, M., Sakurai, T., Chen, Y., Emma‐Okon, B., Wilhite, B., Fukuda, D., Vaisman, B. L., Pryor, M., Wakabayashi, Y., et al. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600142 · Cited by 29
Self-citationThe vascular biology of peroxisome proliferator-activated receptors: Modulation of atherosclerosis
Verma, S., & Szmitko, P. E. (2006) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(06)70981-3 · Cited by 29
Klappacher, G., & Glass, C. K. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200206000-00011 · Cited by 32
Glitazonas e síndrome metabólica: mecanismos de ação, fisiopatologia e indicações terapêuticas
Gomes, M. B. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000200013 · Cited by 40
Recent advances in antitumor Pt(IV) complexes: Dual targeting and chemoimmunotherapy
Spector, D. V., Zharova, A., Bykusov, V., Karetnikov, G. L., Beloglazkina, E. K., & Krasnovskaya, O. O. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.216808 · Cited by 29
Astrocyte Elevated Gene-1 (AEG-1) Regulates Lipid Homeostasis
Robertson, C. L., Srivastava, J., Siddiq, A., Gredler, R., Emdad, L., Rajasekaran, D., Akiel, M., Shen, X., Corwin, F. D., Sundaresan, G., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.661801 · Cited by 30
“It has been documented that LXR and PPAR may indirectly regulate each other (38).”
BackgroundNuclear receptor mediated mechanisms of macrophage cholesterol metabolism
Nagy, Z. S., Czimmerer, Z., & Nagy, L. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.04.003 · Cited by 31
Zhou, L., Shi, Y., Guo, R., Liang, M., Zhu, X., & Wang, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098578 · Cited by 28
“It has been shown that PPARs play a regulatory role in the first steps of the reverse-cholesterol-transport pathway [42].”
BackgroundLi, D., Xiong, Q., Peng, J., Hu, B., Li, W., Zhu, Y. Z., & Shen, X. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050635 · Cited by 27
Ito, F. (2020) · Current Molecular Pharmacology · doi:10.2174/1874467213666200320153410 · Cited by 30
Chen, K., Ma, Z., Yan, X., Liu, J., Xu, W., Li, Y., Dai, Y., Zhang, Y., & Xiao, H. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00528 · Cited by 27
Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Ligands and Their Therapeutic Utility
Henke, B. R. (2004) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(04)42001-3 · Cited by 29
Fujimura, T., Sakuma, H., Ohkubo‐Suzuki, A., Aramori, I., & Mutoh, S. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.423 · Cited by 27
Cardiovascular disease and heritability of the prothrombotic state
Ajjan, R., & Ariëns, R. A. S. (2008) · Blood Reviews · doi:10.1016/j.blre.2008.07.001 · Cited by 36
Nicotinic Acid Receptor GPR109A Is Down-Regulated in Human Macrophage-Derived Foam Cells
Chai, J. T., Digby, J. E., Ruparelia, N., Jefferson, A., Handa, A. I., & Choudhury, R. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062934 · Cited by 30
Guo, C. H., Li, Y., Gow, C., Wong, M., Zha, J., Yan, C., Liu, H., Wang, Y., Burris, T. P., & Zhang, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.598797 · Cited by 32
“The following is a list of primers used for RT-qPCR in MEFs (all sequences are from 5 to 3 ): Fzd1, GTGCTCACGTACCTAGTGGACA and TCCTCCAACAGAAAGCCAGCGA; Socs1, AGTCGCCAACGGAACTGCTTCT and GTAGTGCTCCAGCAGCTCGAAA; Sgk1, AACAGAGAAGGATGGGCCTGAAC and GTTCATAAGCTCCGGCTCCTGAG; Trerf1, AGATGCCTGTGCTCGTGAGGAT and AACTTTGGCGGCGATA…”
Therapeutic Effects of Fibrates in Postprandial Lipemia
Kolovou, G. D., Kostakou, P. M., Anagnostopoulou, K. K., & Cokkinos, D. V. (2008) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200808040-00004 · Cited by 29
Roles of peroxisome proliferator-activated receptor γ in cardiovascular disease
Takano, H., & Komuro, I. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00203-3 · Cited by 30
Pahnke, J., Bascuñana, P., Brackhan, M., Stefan, K., Namasivayam, V., Koldamova, R. P., Wu, J., Möhle, L., & Stefan, S. M. (2021) · Free Neuropathology · doi:10.17879/freeneuropathology-2021-3528 · Cited by 36
Lazarus, H. M., Pitts, K., Wang, T. S., Lee, E., Buchbinder, E. L., Dougan, M. L., Armstrong, D. G., Paine, R., Ragsdale, C. E., Boyd, T. D., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1069444 · Cited by 34
“As reviewed above in Emerging biology of GM-CSF, GM-CSF deficiency impairs the expression of PPAR-g, a key cholesterol regulator, leading to surfactant lipid accumulation within foamy alveolar macrophages (116, 117).”
BackgroundSoumian, S., Gibbs, R. G. J., Davies, A. H., & Albrecht, C. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.026161 · Cited by 30
Effects of gemfibrozil treatment on vascular reactivity of streptozotocin-diabetic rat aorta
Ozansoy, G., & Akin, F. B. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022737 · Cited by 25
“This process, whereby HDL removes cholesterol from arterial macrophage foam cells to be transported to the liver, involves increased hepatic uptake of HDL cholesterol and increased biliary secretion and increased cholesterol excretion (Leiss et al 1985; Chianale et al 1996; Chinetti et al 2001).”
BackgroundYasugi, E., Horiuchi, A., Uemura, I., Okuma, E., Nakatsu, M., Saeki, K., Kamisaka, Y., Kagechika, H., Yasuda, K., & Yuo, A. (2006) · Development Growth & Differentiation · doi:10.1111/j.1440-169x.2006.00855.x · Cited by 28
“Recently, the opposite theory was proposed, namely that PPARγ activation by rosiglitazone is not related to lipid accumulation in macrophages (Chinetti et al. 2001; Moore et al. 2001; Vosper et al. 2001).”
BackgroundZinc finger protein ZNF202 structure and function in transcriptional control of HDL metabolism
Schmitz, G., Heimerl, S., & Langmann, T. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200404000-00013 · Cited by 29
The human myeloperoxidase gene is regulated by LXR and PPARα ligands
Reynolds, W. F., Kumar, A. P., & Piedrafita, F. J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.119 · Cited by 30
Connolly, J. C., Ishihara, Y., Sawaya, E., Whitfield, V., Garrity, N., Sohata, R., Tsymbal, M., Lundberg, A., Merrill, M. A. L., DeWitt, J. C., et al. (2025) · Cardiovascular Toxicology · doi:10.1007/s12012-025-10048-w · Cited by 30
Jiang, M., & Li, X. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.11.123 · Cited by 26
Yanai, H., Adachi, H., Hakoshima, M., & Katsuyama, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073418 · Cited by 27
The PPAR alpha agonist gemfibrozil is an ineffective treatment for spinal cord injured mice
Almad, A., Lash, A. T., Wei, P. Y., Lovett‐Racke, A. E., & McTigue, D. M. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.09.023 · Cited by 27
Role of Adipose Tissue in Metabolic System Disorders
Rezaee, F. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.s13-008 · Cited by 37
Zanotti, I., Potì, F., Favari, E., Steffensen, K. R., Gustafsson, J.-Α., & Bernini, F. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.093930 · Cited by 25
“proliferator-activated receptor (Chinetti et al., 2001), liver X”
BackgroundBrand‐Herrmann, S., Kuznetsova, T., Wiechert, A., Stolarz, K., Tikhonoff, V., Schmidt‐Petersen, K., Telgmann, R., Casiglia, E., Wang, J., Thijs, L., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400405-jlr200 · Cited by 27
Alaaeddine, R. A., Elzahhar, P. A., AlZaim, I., Abou-Kheir, W. G., Belal, A. S. F., & EL‐Yazbi, A. F. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327999200820173853 · Cited by 29
Lin, Z., Zhang, Z., Solberg, M. F., Chen, Z., Wei, M., Zhu, F., Jia, C., Meng, Q., & Zhang, Z. (2021) · Aquaculture Research · doi:10.1111/are.15455 · Cited by 24
Zhou, J., Yu, J., & Chu, Q. (2024) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2024.109386 · Cited by 28
Tanabe, J., Tamasawa, N., Yamashita, M., Matsuki, K., Murakami, H., Matsui, J., Sugimoto, K., Yasujima, M., & Suda, T. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00810.x · Cited by 24
Levula, M., Airla, N., Oksala, N., Hernesniemi, J. A., Pelto‐Huikko, M., Salenius, J., Zeitlin, R., Järvinen, O., Huovila, A. J., Nikkari, S. T., et al. (2009) · Annals of Medicine · doi:10.1080/07853890903025945 · Cited by 26
Mohamed, D. A., Hamed, T. E.-S., & Al‐Okbi, S. Y. (2010) · Grasas y Aceites · doi:10.3989/gya.021210 · Cited by 24
“Several studies indicated that RxR and its heterodimers have the potential to reduce atherosclerosis by affecting lipid metabolism (Chinetti et al., 2001), cell migration (Day et al., 2006), apoptosis (Ji et al., 2001) and inflammation (Marx et al., 1999).”
BackgroundPeroxisome proliferator activated receptor (PPAR)-gamma concentrations in childhood obesity
Akyürek, N., Aycan, Z., Çetinkaya, S. Ç., Akyürek, Ö., Ağladıoğlu, S. Y., & Ertan, Ü. (2013) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2013.786121 · Cited by 23
Role of Peroxisome Proliferator-Activated Receptor-γin Vascular Inflammation
Ohshima, K., Mogi, M., & Horiuchi, M. (2012) · International Journal of Vascular Medicine · doi:10.1155/2012/508416 · Cited by 29
Li, S., Wang, C., Li, K., Li, L., Tian, M., Xie, J., Yang, M., Jia, Y., He, J., Gao, L., et al. (2016) · Scientific Reports · doi:10.1038/srep26746 · Cited by 22
Gurnell, M. (2007) · PPAR Research · doi:10.1155/2007/83593 · Cited by 24
“In addition, the nuclear receptor LXRα (liver X receptor α), which enhances expression of ABCA1 (ATP-binding cassette transporter A1), a protein which mediates cellular cholesterol efflux [102], has also been shown to be a PPARγ target gene in human and mouse macrophages [103, 104].”
BackgroundWu, C., Zhao, Y., Chen, R., Liu, D., Liu, M., Proksch, P., Guo, P., & Lin, W. (2016) · RSC Advances · doi:10.1039/c6ra00033a · Cited by 26
Kavanagh, I. C., Symes, C. E., Renaudin, P., Nova, E., Mesa, M. D., Boukouvalas, G., Leake, D. S., & Yaqoob, P. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00148-5 · Cited by 25
Gene Expression in Atherogenesis
Monajemi, H., Arkenbout, E. K., & Pannekoek, H. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616238 · Cited by 24
“Finally, recently, three “back-to-back” papers provided a rationale for the puzzling effect of PPAR γ activation on atherosclerosis (72-74).”
Chen, C.-H., Leu, S.-J. J., Hsu, C., Pan, C.-C., Shyue, S., & Lee, T. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154847 · Cited by 28
Recent advances in nuclear receptors-mediated health benefits of blueberry
Zou, H., Ye, H., Zhang, J., & Ren, L. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154063 · Cited by 24
Ram, V. J. (2003) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8012-1_3 · Cited by 24
Montanaro, M. A., González, M. S., Bernasconi, A. M., & Brenner, R. R. (2007) · Lipids · doi:10.1007/s11745-006-3006-4 · Cited by 23
APOE dependent-association of PPAR-γ genetic variants with Alzheimer's disease risk
Combarros, O., Rodríguez‐Rodríguez, E., Mateo, I., Vázquez‐Higuera, J. L., Infante, J., Berciano, J., & Sánchez‐Juan, P. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.07.004 · Cited by 24
Reverse cholesterol transport in type 2 diabetes mellitus
Tan, K. C. B. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.01012.x · Cited by 26
Transcriptional regulation of macrophage cholesterol trafficking by PPARα and LXR
Chinetti, G., Fruchart, J., & Staels, B. (2006) · Biochemical Society Transactions · doi:10.1042/bst0341128 · Cited by 30
Self-citationInnate immune system regulation of nuclear hormone receptors in metabolic diseases
Chow, E. K., Razani, B., & Cheng, G. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1206741 · Cited by 25
ABCA1 increases extracellular ATP to mediate cholesterol efflux to ApoA-I
Lee, J. Y., Karwatsky, J., Ma, L., & Zha, X. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00042.2011 · Cited by 23
Inhibition of cytokine production by the herbicide atrazine
Devos, S., Bosscher, K. D., Staels, B., BAUER, E. R. S., Roels, F., Berghe, W. V., Haegeman, G., Hooghe, R. J., & Hooghe-Peters, E. L. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01507-1 · Cited by 23
Self-citationTherapeutic interventions targeted at the augmentation of reverse cholesterol transport
Toth, P. P., & Davidson, M. H. (2004) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000126583.35391.eb · Cited by 23
Metabolic abnormalities: high-density lipoproteins
Barter, P. J. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.006 · Cited by 27
ATP-binding cassette A1 protein and HDL homeostasis
Owen, J. S., & Mulcahy, J. V. (2002) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(02)00043-0 · Cited by 28
Peroxisome proliferator-activated receptor γ and atherosclerosis
Marx, N. (2002) · Current Hypertension Reports · doi:10.1007/s11906-002-0056-8 · Cited by 23
Ou, Z., Cheng, Y., Ma, H., Chen, K., Lin, Q., Chen, J., Guo, R., Huang, Z., Cheng, Q., Alaeiilkhchi, N., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05480-5 · Cited by 23
Atheroprotective Effect of Fucoidan in THP-1 Macrophages by Potential Upregulation of ABCA1
Mirza, Z., Al-Saedi, D. A., Saddeek, S., Almowallad, S. J., Al-Massabi, R. F., & Huwait, E. A. (2023) · Biomedicines · doi:10.3390/biomedicines11112929 · Cited by 24
“Data were described as mean ± SEM ( 𝑋(cid:3364) ± SEM), as each experiment was performed either in triplicate or two independent tests.”
BackgroundMethodIjaz, A., Yarlagadda, B. R. G., & Orecchioni, M. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1589629 · Cited by 31
Ma, C., Hua, Y., Yang, S., Zhao, Y., Zhang, W., Miao, Y., Zhang, J., Feng, B., Zheng, G., Li, L., et al. (2025) · Advanced Science · doi:10.1002/advs.202500610 · Cited by 35
Effect of Maxing Shigan Tang on H1N1 Influenza A Virus-Associated Acute Lung Injury in Mice
Zhong, Y., Zhou, J., Liang, N., Liu, B., Lu, R., He, Y., Liang, C., Junbiao, W., Zhou, Y., Hu, M., et al. (2016) · Intervirology · doi:10.1159/000458726 · Cited by 24
Effect of Genistein on Cholesterol Metabolism‐Related Genes in HepG2 Cell
Lu, R., Zheng, Z., Yin, Y., & Jiang, Z. (2019) · Journal of Food Science · doi:10.1111/1750-3841.14725 · Cited by 22
TSLP Exacerbates Septic Inflammation via Murine Double Minute 2 (MDM2) Signaling Pathway
Han, N., Moon, P., Kim, H., & Jeong, H. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091350 · Cited by 23
Potential Therapeutic Agents That Target ATP Binding Cassette A1 (ABCA1) Gene Expression
Haas, M. J., & Mooradian, A. D. (2022) · Drugs · doi:10.1007/s40265-022-01743-x · Cited by 25
Decreased splenic mRNA expression levels of TNF-α and IL-6 in diet-induced obese animals
Lamas, Ó., Martínez, J. A., & Martí, A. (2004) · Journal of Physiology and Biochemistry · doi:10.1007/bf03167074 · Cited by 22
Toh, S.-A. E. S., Millar, J. S., Billheimer, J. T., Fuki, I. V., Naik, S. U., Macphee, C. H., Walker, M., & Rader, D. J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.01.012 · Cited by 24
PPAR Medicines and Human Disease: The ABCs of It All
Apostoli, A. J., & Nicol, C. J. B. (2012) · PPAR Research · doi:10.1155/2012/504918 · Cited by 24
“Primary human macrophages ↑ ABCA1 and LXRαmRNA [52] ↑ apoA1-mediated cholesterol efflux”
BackgroundInfluentialIdentification of Picrasidine C as a Subtype-Selective PPARα Agonist
Zhao, S., Kanno, Y., Li, W., Sasaki, T., Zhang, X., Wang, J., Cheng, M., Koike, K., Nemoto, K., & Li, H. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.6b00883 · Cited by 22
Oxysterols and mesenchymal stem cell biology
Levy, D., de Melo, T. C., Ruiz, J. L. M., & Bydlowski, S. P. (2017) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2017.06.009 · Cited by 23
Alternate transcripts expressed in response to diet reflect tissue-specific regulation of ABCA1
Singaraja, R. R., James, E. R., Crim, J. L., Visscher, H., Chatterjee, A., & Hayden, M. R. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500133-jlr200 · Cited by 25
Zahradka, P. C., Yurkova, N., Litchie, B., Moon, M. C., Rizzo, D. F. D., & Taylor, C. G. (2003) · Springer eBooks · doi:10.1007/978-1-4615-0298-2_15 · Cited by 22
ATP-binding cassette (ABC) transporters in atherosclerosis
Schmitz, G., & Kaminski, W. E. (2002) · Current Atherosclerosis Reports · doi:10.1007/s11883-002-0026-2 · Cited by 25
PPARγ and the thiazolidinediones: molecular basis for a treatment of ‘Syndrome X’?
Sewter, C. P., & Vidal‐Puig, A. (2002) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2002.00187.x · Cited by 26
Orphan nuclear receptors, PXR and LXR: new ligands and therapeutic potential
Gong, H., & Xie, W. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.1.49 · Cited by 22
“The expression of LXRα has been shown to be subject to regulation by other orphan NRs, such as the peroxisome proliferator-activated receptors (PPARs) [28] and LXRα itself [29].”
BackgroundCheng, W., Zhang, Q., Li, B., Cao, J., Jiao, L., Chao, S.-P., Lu, Z., & Zhao, F. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6957900 · Cited by 22
Li, X., Zhao, X., Yu, M., Zhang, M., & Feng, J. (2024) · Animals · doi:10.3390/ani14030430 · Cited by 26
“A previous study reported that PPAR α activator induces the expression of the gene encoding ABCA1 [54].”
BackgroundThe Renoprotective Actions of Peroxisome Proliferator-Activated Receptors Agonists in Diabetes
Thomas, M. C., Jandeleit-Dahm, K. A. M., & Tikellis, C. (2012) · PPAR Research · doi:10.1155/2012/456529 · Cited by 22
Polydatin Inhibits Formation of Macrophage-Derived Foam Cells
Wu, M., Liu, M., Guo, G. F., Zhang, W.-G., & Liu, L. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/729017 · Cited by 25
“Polydatin, one of the major active ingredients in Rhizoma Polygoni Cuspidati, has been recently shown to possess extensive cardiovascular pharmacological activities.”
BackgroundNicholls, S. J., & Uno, K. (2012) · Diabetes and Vascular Disease Research · doi:10.1177/1479164112441477 · Cited by 24
Metadata
- Authors
- Chinetti, G., Lestavel, S., Bocher, V., Remaley, A. T., Neve, B., Torra, I. P., Teissier, E., Minnich, A., Jaye, M., Duverger, N., Brewer, H. B., Fruchart, J.-C., Clavey, V., & Staels, B.
- Affiliations
- Inserm (FR)
- National Institutes of Health (US)
- Sanofi (France) (FR)
- Corresponding author
- Staels, Bart
- Venue
- Nature Medicine
- Published
- 2001-01
- Volume
- 7
- Issue
- 1
- Pages
- 53-58
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1524478189
- Cited by
- 1,170
- References
- 39
- Citations by year
- 2026: 12 · 2025: 29 · 2024: 31 · 2023: 41 · 2022: 25 · 2021: 28 · 2020: 30 · 2019: 20 · 2018: 29 · 2017: 31 · 2016: 38 · 2015: 33 · 2014: 50 · 2013: 37 · 2012: 38
- FWCI
- 99.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- PPARα, PPARγ, ABCA1, cholesterol efflux, foam cells, macrophages, reverse cholesterol transport, liver X receptor alpha, apolipoprotein A-I, Tangier disease, acetylated LDL, CD36, THP-1 macrophages
- MeSH terms
- Base Sequence, Biological Transport, Cells, Cultured, Cholesterol, Foam Cells, Humans, Transcription Factors, DNA Primers, Receptors, Cytoplasmic and Nuclear, ATP-Binding Cassette Transporters, ATP Binding Cassette Transporter 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.